GLP-1 drugs threaten packaged food sales
The bear case argued: weight loss drugs like GLP-1s reduce hunger and calorie consumption, threatening billions in annual revenue for packaged food makers as a significant portion of the population adopts them.
Sign in to read the full idea
The argument, what validates it, the risks discussed and hearing it from the source are for signed-in members. Free accounts read 3 ideas in full a day. No card required.
The story so far
CONTESTED · 5 MENTIONS · 3 EPISODES · 3 SHOWS
1 SUPPORT · 1 CHALLENGE · 2 REPEAT · 1 MENTIONED
- MONETARY MATTERS WITH JACK FARLEY · 2 MENTIONS
- WE STUDY BILLIONAIRES - THE INVESTORS PODCAST NETWORK
- WSJ WHAT'S NEWS · 2 MENTIONS
- GLP-1 drugs threaten packaged food sales · THIS IDEA
- Food makers adapt with protein, fiber, portions
HOW THE SHOWS HAVE DISCUSSED THIS THESIS OVER TIME · NOT A PERFORMANCE RECORD